Aim to evaluate the efficacy and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) modality in patients with early stages glaucoma.
 Material methods. We examined 38 stage primary open-angle uncompensated glaucoma (POAG) (17 stage, 18 advanced stage) before during 12 months after MP-TSCPC treatment (SUPRA device 810, Quantel Medical, France) using modified laser parameters...